Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo.
about
Rhabdovirus Matrix Protein Structures Reveal a Novel Mode of Self-AssociationA ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAsHypoxia enhances the replication of oncolytic herpes simplex virusEnhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinomaOncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.Impact of tumor microenvironment on oncolytic viral therapyVesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesLoss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx.To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways.The role of oncolytic virus immunotherapies to subvert cancer immune evasion.HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic mammalian orthoreovirus.Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling.Low oxygen tension enhances hepatitis C virus replication.Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virus.Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats.Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation.Cytokine-modified VSV is attenuated for neural pathology, but is both highly immunogenic and oncolytic.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.
P2860
Q27653298-7736B35D-B99C-41A9-95FF-DE240D256092Q28279614-2C648E64-0310-48EB-8D6F-2F1543E69F91Q33660631-1807F4F5-CAC6-45C7-8DC6-7E85A3979FB5Q33731148-969609EB-7176-4163-AB5B-6387C91B49B2Q33750535-A94368B1-297C-450F-B6A0-6693E2480B46Q33895533-F006C35A-65EA-40FC-AC66-AA31619879F5Q33913506-529FEAE8-A159-4540-9534-899C7B10F0BDQ33924550-5976F185-A296-4B9A-8B08-F324F78A6D2EQ35139337-AA6E2B81-C5D6-4DD4-8FE3-984BD964CA46Q35210355-FAF78D9E-0A91-4F55-87F1-3A56D6DCBE9FQ35784861-F697A35F-3C9C-4E38-BADE-883D523CB337Q36318160-6F08C9E2-728B-4BE8-913E-5988857179AEQ38218674-073C0977-0604-484A-94FB-0367F8D70C80Q38286116-686B5129-C6D8-4D84-9E43-5660116EF612Q38357137-8C7A4B95-D2FC-456E-A3F7-287600FCA417Q38458133-BA38B1B4-44D1-41A8-B257-189D2979C60CQ38728290-34EA32BA-27CA-4044-8849-667D89D9EDBEQ39179082-34B77076-2DAA-4FBF-961B-FC2BC58CEE9DQ39220382-DB002BD0-7A72-4F58-8753-5E10AAEC2ED0Q39639135-A4C71F5B-F5EB-4454-8EA4-43CF230E497EQ39778777-DE31AAA3-1FC5-4359-8487-79CF8EF85F2EQ39917875-474E9A49-E6E1-4578-B0CD-6BC6316C78AEQ40208131-8237B613-9935-4A18-9EDD-3803EDA98395Q40213652-7E8E0745-D5E9-4876-9902-3B8B7796B23CQ40459832-E3BDB013-2EBB-4A48-9D3C-904F7D1682DCQ41829468-7C5E11CD-455B-4FCE-8927-58CD5A88AE87Q52688581-F150D3B4-8857-4E00-9D68-8A98154F6C0B
P2860
Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@en
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@nl
type
label
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@en
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@nl
prefLabel
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@en
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@nl
P2860
P1433
P1476
Replication and cytopathic eff ...... or cells in vitro and in vivo.
@en
P2093
Christine Naczki
Douglas S Lyles
P2860
P304
P356
10.1128/JVI.78.17.8960-8970.2004
P407
P577
2004-09-01T00:00:00Z